Management

 

  • Robert F. Johnston, Chief Executive Officer, Chairman of the Board
    • Johnston founded Johnston Associates, a venture capital firm, in 1968 to provide seed capital for start-ups emerging in the biotechnology and healthcare fields.
    • During his career, he founded numerous public companies including Sepracor (acquired by Dainippon Sumitomo Pharma Co), Cytogen (acquired by EUSA Pharma), I-STAT (acquired by Abbott), Genex and Envirogen (acquired by Shaw Environmental), and was instrumental in the early formation of many private companies such as Sonomed, Immunicon (acquired by J&J), PharmaStem (formerly Biocyte), Praelux (acquired by Amersham/GE) and Targent (acquired by Spectrum). Mr. Johnston served as CEO of Cytogen and Praelux (formerly SEQ).
    • Additionally, he is a member of the Advisory Council of the Department of Molecular Biology at Princeton University.
    • Johnston received his B.A. from Princeton University and his M.B.A. from New York University.
  • Eric Gilbert, Executive Vice President
    • Gilbert is a seasoned strategic executive with extensive pharmaceutical development, strategy consulting, advisory and management experience.
    • He has extensive experience in life cycle management, developing and implementing accelerated regulatory strategies, generic drug defense, and working with private equity firms to assess acquisitions and refine operational plans.
    • He has served as CEO of Belrose Pharma Inc. and as the President of Professional Service Solutions Inc. (“PSS”), a firm that developed a number of products on a “full outsource” basis for mid-sized European and US companies, including proprietary sNDA and 505(b)(2) products. Beginning with McKinsey & Company, Mr. Gilbert has over 25 years of experience in the healthcare and pharmaceutical industries.
    • Gilbert holds an MBA from the Stanford Graduate School of Business and a BA with Honors and Distinction from Stanford University.
  • Pauliana Hall, Regulatory & Compliance Consultant
    • Hall has 34 years of experience in the Biopharmaceutical industry. She leads a Regulatory & Compliance Consulting Firm with clients including TONIX Pharmaceuticals, Xeris Pharmaceuticals, AllerQuest, MEDACorp, Leerink Swann LLC, BIOTA, Starpharma, AIRES, Clearside Pharmaceuticals and Aradigm Corp.
    • Previously, she was the Vice President, Worldwide Regulatory Affairs, Quality Assurance and Drug Safety at Sepracor Pharmaceutical Inc., responsible for the implementation of a science-based regulatory strategy to expedite the development of single isomers/active metabolites of marketed drugs, new chemical entities and combination products. Previously, she held various hands-on and management positions at Sepracor, Occulon, AstraZeneca, Aventis and Wyeth.
  • Ross Finesmith MD, Clinical Consultant
    • Finesmith is a physician and medical writer with 16 years of experience. He was in clinical practice as a neurologist for 10 years before becoming a medical consultant to the pharmaceutical and healthcare industry.
    • Previously, he was a clinical instructor at the NYU School of Medicine for 5 years. He has written research protocols and presented the results at national medical conferences. He has published 8 articles in medical journals and 4 book chapters.
    • He is currently assisting Zywie with writing protocols, regulatory documents, and articles for academic groups, pharmaceutical and medical device companies. He managed the meta-analysis, drawing on his extensive experience editing manuscripts to prepare for publication.
    • He has a degree from NC-Greensboro in Neurophysioloogy and an M.D. from The Chicago Medical School.
  • Tony Wang, Ph.D, Statistical Consultant
    • Wang is a PhD Statistician with over ten years of experience in design and analysis of clinical trial, longitudinal data analysis, survival analysis, survey methodology, predictive modeling, and Bayesian methods for clinical trials.
    • He has experience designing analyses and completing statistical analyses for peer-reviewed publications.
    • He received a PhD from University of North Carolina at Chapel Hill and his MD from the Anhui Medical University.